Highlights
NASDAQ: CTIC       Cti Biopharm Corp
Last Price Today's Change   Day's Range   Trading Volume
3.21   -0.11 (3.31%)  3.18 - 3.48  425,300

Overview

 
Avg Volume (4 weeks):453,815
4 Weeks Range:3.10 - 3.61
4 Weeks Price Volatility (%):
21.57%
52 Weeks Range:0.62 - 4.032
52 Weeks Price Volatility (%):
75.91%
Average Price Target: 3.00
Price Target Upside/Downside: -0.21

Headlines



No recent Headlines for this stock.


Business Background

CTI Biopharma Corp is a biopharmaceutical company focused on the development and commercialization of less toxic, more effective cancer therapies. The company's therapeutic area is blood-related cancers. One of the company's products, Pixantrone (PIXUVRI), received conditional marketing approval in the EU in 2012 to treat refractory aggressive B-cell non-Hodgkin lymphoma. Another product is Pacritinib, an oral tyrosine kinase inhibitor to treat mutations such as Janus associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3).

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2563  6639  404  79 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NAKD 1.38+0.988 
 AMC 19.90-0.44 
 NOK 6.55+1.56 
 SNDL 0.60+0.10 
 CTRM 0.532+0.182 
 BB 25.10+4.85 
 EXPR 9.55+1.62 
 GNUS 3.06+1.43 
 UVXY 13.87+2.47 
 AAL 16.56+1.14